Be The General Contractor: Build Your Double-Digit-Yielding Portfolio

Outsource the Expertise: Don't waste time mastering biotech or commercial debt; use the specialized skills of institutional managers at abrdn Healthcare Investors and Apollo Commercial Real Estate Finance to do it for you. 11.1% Yield in Healthcare: Capitalize on the aging U.S. demographic with HQH, which just declared its highest quarterly dividend since 2015. Ride along with ARI as they convert their $9B loan portfolio into a massive cash pile to hunt for high-return M&A opportunities.

Seeking Alpha • Feb 20, 2026

Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026).

PRNewsWire • Feb 10, 2026

HQH: Sentiment And Fundamentals Disconnect Presents Opportunity

abrdn Healthcare Investors (HQH) offers exposure to a recovering healthcare sector, yet trades at an ~8% discount to NAV. HQH's portfolio emphasizes late-stage and commercial-stage healthcare companies, benefiting from reduced Medicare policy uncertainty and sector stabilization. The fund's high yield (~12%) is fully supported by realized gains, not return of capital or net investment income.

Seeking Alpha • Jan 28, 2026

2 Picks To Turn Savings Into Retirement Paychecks: Yields +10%

Your retirement passions and plans are unique; don't settle for cookie-cutter plans. Our Income Method allows you to command your savings to generate reliable paychecks. We discuss two resilient, cash-generating solutions for retirement income, emphasizing reliability and portfolio durability over asset sales.

Seeking Alpha • Jan 20, 2026

This Is How I Would Invest $100,000 In 2026

Income investing emphasizes discipline and resilience against market unpredictability. We discuss our top picks for 2026, where you can invest $100,000 for a resilient income stream. Give yourself the gift of predictable income in the new year.

Seeking Alpha • Jan 1, 2026

30%+ Total Returns In 2025: Embrace Our 3 High-Income Momentum Picks For 2026

Healthcare is positioned for a higher 2026 distribution as healthcare demand remains a powerful force. Agency MBS Recovery: The steepening yield curve is a massive tailwind for AGNC (13.3% yield), providing "safety" yield that often rallies when the broader market struggles. Commodity Resilience captures the shift toward structurally higher prices, with mining and energy acting as essential inflation hedges.

Seeking Alpha • Dec 30, 2025

4 Closed-End Fund Buys In The Month Of November 2025

November presented a pullback primarily in the mega-cap tech, but one that was fairly shallow with a recovery toward the month's end. With that said, there were some opportunities presented with the added volatility for the month. I add to my closed-end fund portfolio positions to help generate a long-term cash flow snowball that increases every month.

Seeking Alpha • Dec 15, 2025

The Flavor Of Resilience: Why Essential Sectors Still Deliver; Yields +11%

REITs and healthcare are indispensable sectors for the modern economy. Both are currently out of favor due to higher interest rates and the fear of tariffs and regulations. It pays to be patient, and we discuss two time-tested picks from both sectors that offer yields of up to 12%.

Seeking Alpha • Dec 14, 2025

HQH: Seeing Strong Recent Returns While Attractively Discounted

abrdn Healthcare Investors offers a discounted entry into the healthcare sector, with a strong tilt toward biotechnology exposure and active management. HQH has recently outperformed both the S&P 500 and biotech benchmarks, driven by relatively smaller-cap or lesser-known holdings like QURE, ALNY, ARGX, and CYTK. HQH suits more aggressive investors comfortable with volatility over the long term, or can appeal to tactical exposure to a recovering biotech sector via a discounted CEF structure.

Seeking Alpha • Nov 17, 2025

HQH: Severely Underperforms Peers (Rating Downgrade)

abrdn Healthcare Investors is downgraded to a sell due to persistent underperformance and heavy concentration in Biotechnology. HQH offers a high dividend yield of 11.3%, but its income focus comes at the expense of long-term capital appreciation and NAV growth. Peers like THQ and THW provide better diversification across healthcare sub-sectors and have delivered superior total returns over the past decade.

Seeking Alpha • Nov 9, 2025